Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.

Virology journal - 15 Jan 2011

Ali Liaqat, Idrees Muhammad, Ali Muhammad, Rehman Irshad-ur, Hussain Abrar, Afzal Samia, Butt Sadia, Saleem Sana, Munir Saira, Badar Sadaf

Abstract excerpt

Hepatitis B virus (HBV) is one of the leading health problem with up to 350 million affected people worldwide including 4.5 million only in Pakistan. It has mortality rate of 0.5 to 1.2 million per year worldwide. Pakistan lies in the endemic region with 3-5% HBV carrier rate in the country. The present article reviews the literature on the treatment response of HBV prevalent in Pakistani population. The average...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepatitis B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Lamivudine

Share to Pakistan

Share to Polyethylene Glycols

Source

Open in PubMed Open full text

Identifiers

PMID: 21235813
DOI: 10.1186/1743-422X-8-20
PMCID: PMC3027132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.PMID 21235813Read ↗

Effect of Pegylated-interferon (Peg-inf) Plus Ribavirin (Rbv) Therapy on Haematological Profile of Different Age Groups Infected by Hepatitis C Virus in PakistanSemantic proximity Read ↗

Diagnosis, Management And Prevention Of Hepatitis C In Pakistan 2017.Semantic proximity Read ↗

Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes.Semantic proximity Read ↗

Hepatitis B virus in Pakistan: serological marker prevalence, clinical correlates, and genotype-informed interpretationSemantic proximity Read ↗

Optimum predictors of therapeutic outcome in HCV patients in Pakistan.Semantic proximity Read ↗

Distribution of hepatitis C virus genotypes and its response to treatment in Pakistani patients.Semantic proximity Read ↗

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.Semantic proximity Read ↗

Time for change: conventional interferon regimes should not be the standard of care for management of Pakistani genotype-3 in chronic hepatitis C.Semantic proximity Read ↗

Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of LiteratureSemantic proximity Read ↗

Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan.Semantic proximity Read ↗

Hepatitis B virus genotypes: "clinical & therapeutic implications".Semantic proximity Read ↗

Therapeutic Efficacy of Entecavir and Tenofovir among the Affectees from War against Terror in the Tribal Areas of PakistanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.